1064P Genomic characterization of first line advanced or metastatic non-small cell lung cancer (aNSCLC) patients (pts) subgroups associated with good/bad prognosis

Autor: Provencio Pulla, M., Perez Parente, D., Campos Balea, B., Rodriguez Abreu, D., Hasan, H., Olson, S., Pal, N., Wilkinson, S., De Oro Pulido, F., Ruiz Gracia, P., Cobo Dols, M.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S1040-S1041

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis.

Autor: García Campelo MR; Medical Oncology, University Hospital A Coruña (XXIAC-SERGAS), 15006 A Coruña, Spain., Arriola E; Medical Oncology, Hospital Universitari del Mar-CIBERONC, 08003 Barcelona, Spain., Campos Balea B; Medical Oncology, Hospital Universitario Lucus Augusti, 27003 Lugo, Spain., López-Brea M; Medical Oncology, Hospital Marqués de Valdecilla, 39008 Santander, Spain., Fuentes-Pradera J; Medical Oncology, Hospital Universitario Nuestra Señora de Valme, 41014 Sevilla, Spain., de Castro Carpeno J; Medical Oncology, Hospital Universitario La Paz, IdiPAZ, 28029 Madrid, Spain., Aguado C; Medical Oncology, Hospital Clínico San Carlos, 28040 Madrid, Spain., Pérez Parente D; Medical Affairs Department, Roche Farma S.A., 28042 Madrid, Spain., de Oro Pulido F; Medical Affairs Department, Roche Farma S.A., 28042 Madrid, Spain., Ruiz-Gracia P; Medical Affairs Department, Roche Farma S.A., 28042 Madrid, Spain., Rodríguez-Abreu D; Medical Oncology, Hospital Universitario Insular de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.

Publikováno v: Journal of clinical medicine [J Clin Med] 2021 Oct 04; Vol. 10 (19). Date of Electronic Publication: 2021 Oct 04.